Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mapplebe
    Junior Member
    • May 2011
    • 7

    #1

    Prep a damaged sample?

    I have several bacterial strains that I am generating RNAseq libraries for. I have collected 4 biological replicates of each, in sets where all of the strains were grown on the same day. All of the bio reps were grown and collected with as little variation as possible, including using the same bottle of media that has now been used up.

    Of course I screwed up one of the replicates. The cell pellets sat on the bench for too long before going into the bead beater to be lysed, and my total RNA yield dropped by 30-70% (from 10 ug usually obtained).

    So now I have the dilemma - I still have enough RNA from each sample in the damaged set that I could technically create a library, but I am not sure if it is worth the cost of the reagents necessary to do so or if the data would be reliable.

    I could technically generate a new replicate set, but it will probably have a lot of extra variation compared to the other bio reps because it will have to be grown with a new bottle of media.

    I could also just go ahead with 3 biological replicates instead of 4, but I am reluctant to lose the statistical power.

    Does anyone here who has examined their RNAseq data have any opinion they'd be willing to share as to which option may better? I know there is no optimal option, but I would like to salvage the situation in the best manner.
    Last edited by mapplebe; 03-03-2015, 02:06 PM.

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    Yesterday, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 02:55 AM
0 responses
8 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Working...